Carol Ward

5.4k total citations
13 papers, 259 citations indexed

About

Carol Ward is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Carol Ward has authored 13 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Carol Ward's work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Carol Ward is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Carol Ward collaborates with scholars based in United Kingdom, Switzerland and United States. Carol Ward's co-authors include C. Evans, Ian Dransfield, Christopher Haslett, Adriano G. Rossi, L. Mauriac, Rodica Morariu-Zamfir, Barbara Eichhorst, Francesco Cognetti, Kirsten Fischer and Anton W. Langerak and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carol Ward

13 papers receiving 247 citations

Peers

Countries citing papers authored by Carol Ward

Since Specialization

Citations

This map shows the geographic impact of Carol Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Ward more than expected).

Fields of papers citing papers by Carol Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Ward. The network helps show where Carol Ward may publish in the future.

Co-authorship network of co-authors of Carol Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Ward. A scholar is included among the top collaborators of Carol Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Ward. Carol Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials 2023 ·SHILAP Revista de lepidopterología ·Lale Kostakoğlu, Maurizio Martelli, Laurie H. Sehn, Andrew Davies, Marek Trněný, Michael Herold, Umberto Vitolo, Wolfgang Hiddemann, Judith Trotman, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Şahin, Gila Sellam, Carol Ward, Anas Younes	1
2	Recil 2017 Criteria Demonstrated Similar Prognostic Value and Detected a Comparable Treatment Difference between Obinutuzumab- and Rituximab-Chemotherapy Compared with Cheson 2007 and Lugano 2014 Criteria in Patients with Previously Untreated Advanced-Stage Follicular Lymphoma 2020 ·Blood ·Lale Kostakoglu, Andrew Davies, Michael Herold, Wolfgang Hiddemann, Robert Marcus, Judith Trotman, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Şahin, Carol Ward, Anas Younes	1
3	Complete Response Status According to RECIL 2017 Criteria Shows High Concordance with Lugano 2014 Criteria and Is Highly Prognostic for Outcome in Previously Untreated Patients with CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL) 2019 ·Blood ·Lale Kostakoğlu, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Umberto Vitolo, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Şahin, Gila Sellam, Carol Ward, Anas Younes	2
4	A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL 2017 ·Blood ·Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle‐Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek	50
5	Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia 2017 ·Leukemia & lymphoma ·Carolyn Owen, Anna Christofides, Nathalie A. Johnson, Tatiana Lawrence, David MacDonald, Carol Ward	8
6	A Model for Predicting Effect of Treatment on Progression-Free Survival Using Minimal Residual Disease As a Surrogate Endpoint in Chronic Lymphocytic Leukemia 2015 ·Blood ·Natalie Dimier, Paul Delmar, Carol Ward, Rodica Morariu-Zamfir, Günter Fingerle‐Rowson, Jasmin Bahlo, Kirsten Fischer, Barbara Eichhorst, Valentin Goede, Jacques J. M. van Dongen, Matthias Ritgen, Sebastian Böttcher, Anton W. Langerak, Michael Kneba, Michael Hallek	3
7	Granulocyte Apoptosis and Macrophage Clearance of Apoptotic Cells as Targets for Pharmacological Intervention in Inflammatory Diseases 2006 ·Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry ·(unknown), Carol Ward, Deborah A. Sawatzky, Tara A. Sheldrake, Ian Dransfield, Christopher Haslett, Adriano G. Rossi	4
8	Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group 2005 ·Journal of Clinical Oncology ·(unknown), Francesco Cognetti, D Maraninchi, (unknown), L. Mauriac, M. Tubiana-Hulin, Stephen L. Chan, David Robert Grimes, Antonio Antón, Aňa Lluch, John Kennedy, Kenneth J. O’Byrne, Pierfranco Conté, Michael Green, Carol Ward, (unknown), Jean-Marc Extra	68
9	Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist‐induced activation and retardation of apoptosis 2003 ·British Journal of Pharmacology ·Joanna Murray, Carol Ward, Joseph T. O’Flaherty, Ian Dransfield, Christopher Haslett, Edwin R. Chilvers, Adriano G. Rossi	29
10	Myeloma affects both the growth and function of human osteoblast-like cells 1992 ·Clinical & Experimental Metastasis ·C. Evans, Carol Ward, (unknown), (unknown)	30
11	Effect of donor age on the growth in vitro of cells obtained from human trabecular bone 1990 ·Journal of Orthopaedic Research® ·C. Evans, (unknown), Carol Ward	44
12	Delayed Hypersensitivity Skin Testing Does Not Influence the Management of Surgical Patients 1982 ·Annals of Surgery ·Roger F. Brown, J Bancewicz, (unknown), Glenn Tillotson, Carol Ward, M H Irving	12
13	SKIN-BIOPSY SITE AND SUCCESSFUL FIBROBLAST CULTURE 1973 ·The Lancet ·MarkW. Steele, (unknown), Carol Ward	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact